What if we had better ways to predict cancer and a tailored plan to intervene early in the process? Dr. Adam Kinnaird is conducting leading edge research in the area of prostate cancer, which affects 1 in 7 men in Canada throughout their life. We talk about his research into early interventions in cancer, why prostate cancer is so hard to diagnose, using AI/ML techniques in precision diagnostics, surgical robots, interdisciplinary research collaboration and why he’s excited about the future of precision medicine.
“Prostate cancer is a spectrum, [from low to high risk]…my particular research looks at the patient population for low risk prostate cancer…and doing active surveillance. We’re trying to better risk stratify men…we are using advanced imaging techniques, MRI and micro-ultrasound …as well as next generation genetic sequencing… We’re trying to come up with a composite risk score at the individual patient level.” – Adam Kinnaird
Dr. Adam Kinnaird is Assistant Professor, Faculty of Medicine and Dentistry, surgery department, at the University of Alberta. He is a urological surgeon and graduated as a Vanier Scholar with the Governor General’s Gold Medal at the University of Alberta. Dr. Kinnaird is an award-winning researcher and recently completed an international fellowship at UCLA.
